Cyclin D1 complies with the concept of oncogenic addiction described by Weinstein and Joe [60]—i.e., dependency of carcinogenic cells on the expression of some oncoproteins, which allows them to survive and maintain their proliferation—which implies that the therapeutic blockage of a single protein could have benefits in the treatment of the tumor. The gene discussed is CCND1; the disease is neoplasm.